Thomas Foster is a Neurology physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3280 Dauphin St Bldg A
Mobile, AL 366064060
Telephone
251-450-3700Provider last certified this registry record 28 May 2025.
Industry payments
25 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202516 payments
- Biogen, Inc.Program year20251 payment
- Amgen Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
55.5%Neuromuscular Blocker51.2%Onabotulinumtoxina99%Botox1%Part D + Part B≥22 patientsMuscle Relaxant1.8%Methocarbamol100%Part D≥83 patients+ 3 more classes in this area
Nervous system
41%Gabapentinoids6.7%Gabapentin73%Pregabalin27%Part D≥132 patientsTricyclic Antidepressant4%Nortriptyline Hcl57%Doxepin Hcl34%Amitriptyline Hcl9%Part D≥82 patients+ 22 more classes in this area
Cardiovascular
1.1%Beta blocker1%Propranolol Hcl Er63%Metoprolol Succinate21%Propranolol Hcl16%Part D<11 patientsAntiarrhythmic0.1%Lidocaine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”